HPVC2019-058 Pharmaceutical Products and IV Fluids
Current Contract
Description
Contract for the provision of a range of pharmaceutical products and intravenous fluids to Victorian Public Health Services.Additional Information
Update: 14 September 2023
Title: HPVITS2019-058.015 Pharmaceutical Products and IV Fluids Supplementary 15
HSV has made an update to Supplementary 015. Please find the updated information as below:
Tentative dates:
Announcement of outcome to suppliers: 7 September 2023
Announcement of outcome to health services: 18 September 2023
Contract Commencement Date: 29 September 2023
Scope:
|
SUBCATEGORY NUMBER |
SUBCATEGORY NAME |
|
551.01 |
BENDAMUSTINE 100 MG INJECTION, AMPOULE/VIAL |
|
551.02 |
BENDAMUSTINE 25 MG INJECTION, AMPOULE/VIAL |
|
531.01 |
BIVALIRUDIN 250MG INJECTION. AMPOULE/VIAL |
|
89.03 |
CEFAZOLIN 2 G INJECTION, AMPOULE/VIAL |
|
552.01 |
CYTARABINE 2000 MG/20 ML INJECTION, AMPOULE/VIAL 20 ML |
|
127.01 |
DEXAMETHASONE PHOSPHATE 4 MG/ML INJECTION, AMPOULE/VIAL 1 ML |
|
127.02 |
DEXAMETHASONE PHOSPHATE 8 MG/2 ML INJECTION, AMPOULE/VIAL 2 ML |
|
553.01 |
FOSAPREPITANT 150 MG INJECTION, AMPOULE/VIAL |
|
554.01 |
GLYCOPYRRONIUM BROMIDE (GLYCOPYRROLATE) 0.5 MG + NEOSTIGMINE 2.5 MG INJECTION, AMPOULE/VIAL 1 ML |
|
300.11 |
MESALAZINE 1.2G PROLONGED RELEASE TABLET |
|
335.01 |
NEBIVOLOL 1.25 MG TABLET 28 |
|
335.02 |
NEBIVOLOL 10 MG TABLET 28 |
|
335.03 |
NEBIVOLOL 5 MG TABLET 28 |
|
555.01 |
SACUBITRIL 24.3 MG + VALSARTAN 25.7 MG TABLET 56 |
|
555.02 |
SACUBITRIL 48.6 MG + VALSARTAN 51.4 MG TABLET 56 |
|
555.03 |
SACUBITRIL 97.2 MG + VALSARTAN 102.8 MG TABLET 56 |
|
443.01 |
SITAGLIPTIN 100 MG TABLET 28 |
|
443.02 |
SITAGLIPTIN 25 MG TABLET 28 |
|
443.03 |
SITAGLIPTIN 50 MG TABLET 28 |
All enquiries regarding this supplementary tender should be directed to s.saw@healthsharevic.org.au or (03) 9947 3935.
Title: HPVITS2019-058.016 Pharmaceutical Products and IV Fluids Supplementary 16
HSV has made an update to Supplementary 016. Please find the updated information as below:
Upcoming Supplementary Tender
Supplier Briefing Date: 20 September 2023
Request For Information Market Release Date: 28 September 2023
Request For Information Market Closing Date: 27 October 2023 14:00 AEDT
Request For Quotation Market Release Date: 20 November 2023
Request For Quotation Market Closing Date: 29 November 2023 14:00 AEDT
Scope:
|
Subcategory number |
Subcategory name |
|
556.01 |
SUGAMMADEX 200 MG/2 ML INJECTION, AMPOULE/VIAL 2 ML |
|
556.02 |
SUGAMMADEX 500 MG/5 ML INJECTION, AMPOULE/VIAL 5 ML |
All enquiries regarding this supplementary tender prior to the market release date should be directed to s.saw@healthsharevic.org.au or (03) 9947 3935. Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.
Tentative dates:
Announcement of outcome to suppliers: 8 December 2023
Announcement of outcome to health services: 15 December 2023
Contract Commencement Date: 15 December 2023
Transition Period Post Contract Commencement: 4 weeks
Title: HPVOPT2019-058 Pharmaceutical Products and IV Fluids Option Review
HSV is currently engaging incumbents of the HPVC2019-058 contract as part of the Option period review.
Useful information:
1. To subscribe and receive contract update notifications, favourite this contract cabinet.
2. Review your account settings to ensure the notification frequency selected is adequate.
3. Information for Prospective Suppliers can be found on our website: https://healthsharevic.org.au/tenders-and-contracts/information-for-new-suppliers/prospective-suppliers/
Categories
Category 1 - Pharmaceutical ProductsCategory 50,000 - Intravenous Fluids
Category 60,000 - Parenteral Nutrition Solutions
Category 70,000 - Irrigating Solutions
Category 80,000 - Biopharmaceuticals
Category 90,000 – Therapeutic Group Approach